2017 Conference on Retroviruses and Opportunistic Infections (CROI)

Protocol

Title

Authors

Presentation Type

P1104s

Neuropsychological outcomes in a two year African-based pediatric observational study

Boivin MJ, Chernoff M, Laughton B, BwakuraDangarembizi M, Kamthunzi P, Barlow-Mosha L, Violari A, Cotton M, Palumbo P, for the IMPAACT P1104s Study Team

Poster

IMPAACT 219C

Biomarkers of cognitive decline in perinatallyinfected children with HIV

Bearden DR, Gill A, Williams PL, Kolson DL, Schankel L, Agwu A, Van Dyke RB, Douglas SD, for the IMPAACT 219C study team

Poster

IMPAACT 219C

Plasma Heme-Oxygenase-1 is associated with cognitive decline in children with HIV

Bearden DR, Gill A, Williams PL, Kolson DL, Schankel L, Agwu A, Van Dyke RB, Douglas SD, for the IMPAACT 219C study team

Poster

P1026s

Interaction between etonogestrel-releasing implant and 3 antiretroviral regimens

Kreitchmann R, Stek A, Best B, Capparelli E, Wang J, Shapiro DE, Chakhtoura N, Burchett S, Mirochnick M

Poster

P1072

B and T cell subsets and immunogenicity of rotavirus vaccine in PHIV and PHEU Infants

Weinberg A, Lindsey JC, Bosch R, Persaud D, Sato P, Heckman B, Richardson K, Zadzilka A, Nelson M, Levin MJ

Poster

PHOENIx IMPAACT 2003/A5300

HIV testing uptake among household contacts of MDR-TB index cases in eight countries

Opollo VS, Wu X, Lando R, Swindells S, Gupta A, Hesseling A, Dawson R, Hughes MD, Shah S

Poster

P1025, DACS 711, SMARTT

TDF/FTC in pregnancy shows no increase in adverse infant birth outcomes in US cohorts

Rough K, Seage III GR, Williams PL, Hernandez-Diaz S, Huo Y, Chadwick EG, Hoffman RM, Barr E, Shapiro DE, Patel K

Poster

P1026s

Elvitegravir/cobicistat pharmacokinetics in pregnancy and postpartum

Best B, Capparelli E, Stek A, Acosta E, Smith E, Chakhtoura N, Wang J, Hernandez A, Mirochnick M

Poster

PROMISE 1077BF/FF

Antenatal antiretroviral therapy and adverse birth outcomes: the PROMISE trial

Chi BH, Farhad M, Owor M, Chipato T, Qin M, Dadabhia S, Gnanashanmugam D, Chakhtoura N, Fowler MG, Stringer JS

Poster

PROMISE 1077BF/FF

Risk factors for low birth weight and preterm delivery in the PROMISE trial

Sebikari D, Qin M, Owor M, Stringer J, Farhad M, Chakhtoura N, Chi B, Klingman K, Theron G, Fowler MG

Poster

PROMISE 1077HS

Subsequent pregnancy outcomes in women during follow-up in PROMISE 1077HS

Pilotto JH, Brummel S, Hoffman RM, Britto P, Masheto G, Aurpibul L, Chakhtoura N, Klingman K, Currier JS

Poster

P1080

Sertraline pharmacokinetics in HIV-infected on ARV and uninfected youth

Hanan N, PAUL M, Huo Y, Capparelli E, Kapetanovic S, Ariansen JL, Smith E, Brouwers P, Best B

Poster

P1093

Dolutegravir pharmacokinetics, safety and efficacy in HIV+ children 2 to <6 years old

Ruel T, Acosta E, Singh RP, Alvero C, George K, Popson S, Vavro C, Hazra R, Wiznia A

Poster

P1106

Pharmacokinetics of nevirapine prophylaxis in HIVexposed low birth weight infants

Bekker A, Violari A, Cababasay M, Wang J, Wiesner L, Capparelli E, Cotton M, Nakwa F, Mirochnick M

Poster

P1110

Raltegravir pharmacokinetics and safety in HIV-1 exposed neonates: dose-finding study

Clarke DF, Acosta EP, Chain A, Wang J, Cababasay M, Teppler H, Smith E, Hazra R, Mirochnick M, and the IMPAACT P1110 Protocol Team

Poster

P1112

Safety & pharmacokinetics of the monoclonal antibody, VRC01, in HIV-exposed newborns

Cunningham CK, McFarland EJ, Capparelli EV, Muresan P, Perlowski C, Valentine M, Smith E, Mascola JR, Graham BS

Poster